FDA NDC Directory · JSON-LD · Markdown

Atovaquone

NDC 31722-629 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerCamber Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA210692
Dosage form / routeSUSPENSION · ORAL
Active ingredientsATOVAQUONE (750 mg/5mL)
Marketing started20181011
Package count1

External sources

Source: openFDA. Public-domain (CC0).